Last updated on January 2020

Intervention of Bladder Cancer by CAR-T

Brief description of study

This is a Phase I/II and multicenter study designed to evaluate the efficacy and safety of 4SCAR-T cells in participants with locally advanced or metastatic urothelial bladder cancer (UBC) who have no further treatment available.

Clinical Study Identifier: NCT03185468

Find a site near you

Start Over